Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model.

Cho EG, Zaremba JD, McKercher SR, Talantova M, Tu S, Masliah E, Chan SF, Nakanishi N, Terskikh A, Lipton SA.

PLoS One. 2011;6(8):e24027. doi: 10.1371/journal.pone.0024027. Epub 2011 Aug 25.

2.
3.

Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells.

Ambasudhan R, Dolatabadi N, Nutter A, Masliah E, Mckercher SR, Lipton SA.

J Comp Neurol. 2014 Aug 15;522(12):2845-56. doi: 10.1002/cne.23617. Epub 2014 May 7. Review.

4.

Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons.

Alwin Prem Anand A, Gowri Sankar S, Kokila Vani V.

J Cell Mol Med. 2012 Nov;16(11):2592-610. doi: 10.1111/j.1582-4934.2012.01607.x. Review.

5.

Myocyte enhancer factor 2C and its directly-interacting proteins: A review.

Dong C, Yang XZ, Zhang CY, Liu YY, Zhou RB, Cheng QD, Yan EK, Yin DC.

Prog Biophys Mol Biol. 2017 Jul;126:22-30. doi: 10.1016/j.pbiomolbio.2017.02.002. Epub 2017 Feb 3. Review.

PMID:
28163053

Supplemental Content

Support Center